EBITDA Growth
11.21%
TTM · Period ending:
EMR EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported11.21%period ending
Latest reported11.21%period ending
EMR TTM EBITDA YoY % (62.17% → 11.21%)
Year-over-year change
High-resolution chart · PNG
EMR ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 5.5424% | |
| 8.9886% | |
| 10.4777% | |
| 15.6228% | |
| 20.8477% | |
| 27.354% | |
| 35.1064% | |
| 28.0243% | |
| 21.3639% | |
| 14.9784% | |
| 8.2437% | |
| 9.7271% | |
| 10.0966% | |
| 10.3627% | |
| 10.8419% | |
| 10.5527% | |
| 10.9245% | |
| 10.996% | |
| 11.5268% | |
| 12.1053% | |
| 6.0608% | |
| 1.4451% | |
| -3.01% | |
| -8.0386% | |
| -2.1532% | |
| 1.5833% | |
| 4.1662% | |
| 7.4779% | |
| 5.4308% | |
| 6.0743% | |
| 7.5847% | |
| 8.853% | |
| 8.0426% | |
| 6.4671% | |
| 4.167% | |
| 2.8151% | |
| 2.4006% | |
| 0.7732% | |
| 0.7063% | |
| 2.3575% | |
| 5.6439% | |
| 9.296% | |
| -47.9172% | |
| -66.2098% | |
| 2,754.2802% | |
| 0.8063% | |
| 143.8396% | |
| 319.9096% | |
| -103.9639% | |
| 12.8885% | |
| 6.2611% | |
| 17.1314% | |
| -15.0707% | |
| -5.5628% | |
| 11.4455% | |
| 12.287% | |
| 62.1668% |